Variant report
Variant | esv19443 |
---|---|
Chromosome Location | chr15:46102589-46118104 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2413794 | chr15:46103010-46103011 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs74010714 | chr15:46103233-46103234 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs370569698 | chr15:46103269-46103270 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs551936461 | chr15:46103281-46103282 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs377024670 | chr15:46103289-46103290 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs571678878 | chr15:46103322-46103323 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs139917434 | chr15:46103333-46103334 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs117383830 | chr15:46103345-46103346 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs112525826 | chr15:46103358-46103359 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs68120365 | chr15:46103368-46103369 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs548877770 | chr15:46103398-46103399 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs536553535 | chr15:46103412-46103413 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs11636751 | chr15:46103423-46103424 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs143414805 | chr15:46103495-46103496 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs544907188 | chr15:46103500-46103501 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs190937569 | chr15:46103530-46103531 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs182835834 | chr15:46103531-46103532 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs146745849 | chr15:46103557-46103558 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs11637752 | chr15:46103573-46103574 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs529617061 | chr15:46103595-46103596 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs538919815 | chr15:46104008-46104009 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs114835994 | chr15:46104024-46104025 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs150285207 | chr15:46104036-46104037 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs374310863 | chr15:46104046-46104047 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs77300023 | chr15:46104047-46104048 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs574179202 | chr15:46104123-46104124 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs539870546 | chr15:46104137-46104138 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs539800698 | chr15:46104170-46104171 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs558145266 | chr15:46104183-46104184 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs559716016 | chr15:46104203-46104204 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs144898885 | chr15:46104225-46104226 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs552008392 | chr15:46104239-46104240 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs149044150 | chr15:46104245-46104246 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs6493178 | chr15:46104254-46104255 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs116002630 | chr15:46104265-46104266 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs145870982 | chr15:46104266-46104267 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs530193540 | chr15:46104270-46104271 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs191732305 | chr15:46104273-46104274 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs183201723 | chr15:46104274-46104275 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs188258043 | chr15:46104299-46104300 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs537949293 | chr15:46104301-46104302 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs192439257 | chr15:46104307-46104308 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs138755649 | chr15:46104311-46104312 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs538079281 | chr15:46104331-46104332 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs554322797 | chr15:46104346-46104347 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs143972976 | chr15:46104433-46104434 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs146787210 | chr15:46104453-46104454 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs538658892 | chr15:46104467-46104468 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs576725663 | chr15:46104495-46104496 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs545399786 | chr15:46104505-46104506 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Schizophrenia | 19415332 | CNVD |
Breast cancer | 22522925 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
cataract | 16735990 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Medulloblastoma | 21979893 | CNVD |
spastic paraplegia with thinning of corpus callosum | 19105190 | CNVD |
Schizophrenia | 21324950 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Disease | 21824424 | CNVD |
Melanoma | 18172304 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Gastric cancer | 17167181 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Intellectual disability | 22102821 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 21785460 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 18632612 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Cancer | 21129771 | CNVD |
Papillary thyroid carcinoma | 22161024 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 21045282 | CNVD |
Breast cancer | 22032731 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Abnormal phenotypes | 18644119 | CNVD |
Cancer | 16751803 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Marfan syndrome | 17492313 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr15:46103000-46103600 | Enhancers | Skeletal Muscle Female | skeletal muscle |
2 | chr15:46104000-46105000 | Enhancers | Adipose Nuclei | Adipose |
3 | chr15:46104000-46105400 | Enhancers | HUVEC | blood vessel |